✦ LIBER ✦

P17 EGFR, K-RAS and HER2 mutations as predictive factors for gefitinib sensitivity in non-small cell lung cancer (NSCLC)

✍ Scribed by A. Voutsina; A. Kalikaki; Y. Ampatziadis-Michailidis; J. Souglakos; A. Koytsopoylos; M. Trypaki; A. Pallis; S. Stathopoylos; D. Mavroudis; V. Georgoulias

Book ID: 118626170
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 50 KB
Volume: 5
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(08)70096-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMD31 Cost-Effectiveness Analysis of EGF

PMD31 Cost-Effectiveness Analysis of EGFR Testing and Gefitinib for Non-Small-Cell Lung Cancer (NSCLC) in Japan

✍ T. Shiroiwa; Y. Miyoshi; K. Tsutani 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PD-159 Mutation in the tyrosine kinase d

PD-159 Mutation in the tyrosine kinase domain of epidermal growthfactor receptor (EGFR) is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer (NSCLC)

✍ Tsai, C.; Chiu, C.; Chou, T.; Li, L.; Chang, K.; Chen, Y.; Tsai, S.; Perng, R. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 139 KB

O-110 EGFR mutations and pAKT expression

O-110 EGFR mutations and pAKT expression as potential predictors ofgefitinib efficacy in non-small cell lung cancer (NSCLC) patients (pts)

✍ Villaflor, V.; Buckingham, L.; Gale, M.; Coon, J.; Mauer, A.; Muzzafar, T.; Kais 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Epidermal growth factor receptor (EGFR)

Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa®, ZD1839) in chemotherapy-resistant non-small cell lung cancer

✍ Sae-Won Han; Pil Gyu Hwang; Doo Hyun Chung; Dong-Wan Kim; Seock-Ah Im; Young Tae 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 351 KB 👁 1 views

## Abstract Gefitinib has shown meaningful antitumor activity with tolerable toxicity in chemotherapy‐refractory NSCLC in previous studies. Moreover, EGFR expression failed to show a correlation with response. In an attempt to identify predictive markers of response, we have investigated the tumora

Predictive Factors for Brain Metastases

Predictive Factors for Brain Metastases and Relapse and Prognostic Factors for Survival in Stage III-IV Non-Small Cell Lung Cancer (NSCLC)

✍ Yoon, H.; Helenowski, I.; Bhandari, R.; Raparia, K.; Marymont, M.; DeCamp, M.; d 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 49 KB

805 Mitogen-activated protein kinase (MA

805 Mitogen-activated protein kinase (MAPK) and Akt as predictive factors for response to ZD 1839 therapy in non-small cell lung cancer (NSCLC) patients

✍ F. Capuzzo; V. Gregorc; K. Bencardino; L. Lombardo; E. Magrini; T.C. Paties; G.L 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 170 KB